Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroma 1 Chronic Pain 1 Breast Neoplasms 1 Agnosia 1

Interventions

Fulvestrant 67 Letrozole 57 Paclitaxel 54 pembrolizumab 42 Trastuzumab 42 ribociclib 39 palbociclib 37 Specimen Handling 37 Capecitabine 36 Anastrozole 35 Tamoxifen 33 Carboplatin 33 exemestane 31 abemaciclib 30 pertuzumab 29 Magnetic Resonance Spectroscopy 27 Cyclophosphamide 27 trastuzumab deruxtecan 25 Surveys and Questionnaires 21 Radiotherapy 21 Blood Specimen Collection 20 Biopsy 19 olaparib 17 Standard of Care 17 Docetaxel 17 eribulin 14 Taxes 14 Mastectomy, Segmental 14 130-nm albumin-bound paclitaxel 14 elacestrant 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Botulinum Toxins, Type A × 90 days × Clear all

NCT06807164 2026-03-27

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting

Agnosia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡